BridgeMD
New treatment option for Dysphonia
Official title Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
ClinicalTrials.gov ID: NCT07176988
What this study is testing
- What it's testing
- This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 65
You may be able to join if
- Non-smoking
- Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
- No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
- No history of voice therapy or voice surgery in the last year
- No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone...
You likely can't join if
- History of voice therapy or voice surgery in the last year
- Serious chronic medical condition that may affect voice (per patient report)
- Abnormal hearing ability (despite appropriate amplification)
- Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
- Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
- Unwillingness to attend therapeutic intervention and follow-up sessions
See the full eligibility criteria
- Non-smoking
- Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
- No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
- No history of voice therapy or voice surgery in the last year
- No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as...
- Willingness to attend all therapeutic interventions and follow-up sessions
- Willingness to use a smartphone to record practice
- History of voice therapy or voice surgery in the last year
- Serious chronic medical condition that may affect voice (per patient report)
- Abnormal hearing ability (despite appropriate amplification)
- Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
- Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
- Unwillingness to attend therapeutic intervention and follow-up sessions
- Unwillingness to use a smartphone to record practice
- Pregnant women
- Prisoners
- Cognitive impairment or impaired decision-making capacity
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.